# A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

> **NCT03769558** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 264 (actual)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT03769558
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-12
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769558, "A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03769558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*